GlassScriptPhysician profile
Matthew D Brockway
NPI 1861079097
$479.00
in general payments reported to CMS, 2019-2025
9 companies · $239 in 2025
The $239 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $16.34 · 2023: $142 · 2024: $81.70 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $463.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $462.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $146.30 | 2024-2025 | Ozempic, Rybelsus |
| Abbvie INC. | $117.96 | 2023 | Rinvoq |
| Kerecis Limited | $58.51 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| E.R. Squibb & Sons, L.L.C. | $40.01 | 2021-2023 | Eliquis |
| Astrazeneca Pharmaceuticals LP | $31.80 | 2024-2025 | Airsupra, Breztri |
| Amgen INC. | $26.46 | 2025 | Krystexxa |
| Mallinckrodt Hospital Products INC. | $22.92 | 2024 | Acthar |
| Urgo Medical North America, LLC | $19.02 | 2024 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4 |
| Boston Scientific Corporation | $16.02 | 2025 | General - Pain Management |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Brockway listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.